Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
about
Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function.Acute Osteoclast Activity following Subchondral Drilling Is Promoted by Chitosan and Associated with Improved Cartilage Repair Tissue Integration.IL-17 in sera from patients with aggressive periodontitisThe impact of inflammation on bone mass in children.Human early fracture hematoma is characterized by inflammation and hypoxiaGolimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH studyCytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritis.Skeletal integrity and visceral transplantationRecent advances in neutralizing the IL-6 pathway in arthritis.Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?Bioinformatics analysis for the antirheumatic effects of huang-lian-jie-du-tang from a network perspectiveDisease Activity and Bone Mineral Density of MCP Joints in Patients with Rheumatoid and Psoriatic Arthritis: Is There a Correlation?-A Study in Patients Treated with Methotrexate and an Anti-TNF α Agent.Effect of γ-tocotrienol in counteracting oxidative stress and joint damage in collagen-induced arthritis in rats.Functions of nuclear factor kappaB in bone.Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.The balance of tissue repair and remodeling in chronic arthritis.Osteoimmunology - Unleashing the concepts.Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases.The dual face of parathyroid hormone and prostaglandins in the osteoimmune system.Potential Role of DARC-Chemokine Interaction in the Recruitment of Osteoclast Precursors in Response to Bacterial Lipopolysaccharide Challenge.Optimal therapy in Gaucher diseaseGolimumab, a human anti–tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function finCombination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats.Structural, cellular, and molecular evaluation of bone erosion in experimental models of rheumatoid arthritis: assessment by μCT, histology, and serum biomarkers.Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies.Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures.Human adipose-derived mesenchymal stem cell-conditioned media suppresses inflammatory bone loss in a lipopolysaccharide-induced murine model.Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies.Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.Axial spondyloarthritis.Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis.
P2860
Q26863571-72CD1353-2FDF-4F23-97F3-926C2FB0C9A4Q33552875-0C493FC4-D7AE-4213-BE42-A43D2AAF2D82Q34991507-6047C629-1ABF-49A3-A8E7-1F7B08545A6AQ35129161-5121F4BE-F78D-49D7-98C2-C3501C42C61FQ35226354-1FB86783-3815-424B-950A-4B281BF47332Q35242582-BA5AA408-D1C2-4400-9097-394A38DC639DQ36023494-FFC2CF8E-5E85-4809-8396-FE73E8F080FEQ36245722-F71CA134-2B72-4A1E-BA04-D9B954719EA2Q36633247-75FD4B78-7AB1-4D3A-8970-07FFF0F83E66Q36908631-05409998-1DA0-4FF4-84A3-45568443756DQ37358099-23333ED6-15E2-4E3A-9C6F-D7D4E316DBD8Q37358225-2D2F553D-7C96-47D9-A08F-E7C6FFD0A4CBQ37375683-15898096-E7CE-48E2-9BB2-B03EA2C2BE48Q37411976-A89D9AAC-8FB9-4F2D-B1C6-EB902F6BE74AQ37710041-08D3F246-16AC-41D0-928F-6987EC3FD4DCQ37730952-15941E9E-25EF-46CF-B1D3-F015B043D10AQ37829690-B95BB35C-0CA9-4724-8795-79499F6E7E83Q37947117-3DF98317-2EF1-4E9A-8907-85EBF12D6AF9Q37949580-1BDCED66-8162-486A-A4BF-EE20EEB6EB76Q38008692-021F49AA-877E-4BF1-8A91-E2BF6F207547Q38138832-226ED8C9-9A65-451F-846C-144222B57A16Q42682224-604135F5-F09B-4D62-BD4A-6BD950BA3799Q42705042-E0CF7467-6C1A-415A-93EA-1157B0D87D0BQ44911715-FC80B741-C2B3-4FF7-9F8F-4EAF4B3E07CDQ45032600-8A616DD3-6E75-421C-B92C-AD8179DAAB73Q46011580-717C601E-960C-402E-A4F8-12C8CF02FCEEQ47429306-7DE514AB-2F12-4218-B5DD-1B995DA9C470Q48023363-18752953-D1A4-4CDD-B00A-D06C63A6560BQ49816092-2E10B763-5323-4539-96E2-F99B0D8F1F70Q50495423-08BE6E0D-6955-4ED2-BB36-05A88327D847Q50589517-F2F05D8E-6EEC-4D3B-90A9-C5B3355CB894Q52870848-D87A50FE-DBB7-4673-88C9-1E456DF37B30Q54286064-9ACDECAA-14E3-4C39-A922-6A37B81798ACQ54374632-C7CFCEC4-5185-4530-ABCD-5ADD6FFAD328Q55265895-7C2B6BFC-6891-4E13-91D1-1076949FD2C5
P2860
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
@en
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
@nl
type
label
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
@en
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
@nl
prefLabel
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
@en
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
@nl
P1476
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
@en
P2093
Gerhard Krönke
Sonja Herman
P304
P356
10.1016/J.MOLMED.2008.04.001
P50
P577
2008-05-09T00:00:00Z